source
- FDA approves AstraZeneca’s novel hypertension pill BaxfendyThe U.S. Food and Drug Administration has cleared AstraZeneca’s new hypertension medication, Baxfendy, marking the first approval of a drug that works by inhibiting a blood‑pressure‑raising enzyme.…
- Merck's China-sourced ADC shows survival benefit in Phase 3 endometrial cancer trialMerck & Co., in partnership with Chinese biotech Kelun-Biotech, reported that its experimental antibody-drug conjugate sacituzumab tirumotecan (Sac-TMT) met its primary endpoint in a global Phase 3…